CN Stock MarketDetailed Quotes
002737 Sunflower Pharmaceutical Group
- 20.86
- -0.04-0.19%
Market Closed Dec 16 15:00 CST
12.18BMarket Cap14.25P/E (TTM)
21.17High20.81Low60.43KlotVolume20.90Open20.90Pre Close126.31MTurnover1.04%Turnover Ratio10.89P/E (Static)584.00MShares29.5952wk High2.72P/B12.18BFloat Cap18.2252wk Low22.99Limit Up584.00MShs Float31.70Historical High18.81Limit Down1.72%Amplitude4.53Historical Low1.50Dividend TTM20.90Avg Price32.50KlotAsk7.19%Div YieldTTM100Lot Size26.56KlotBid
Sunflower Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -41.32%2.51B | -35.82%2.05B | -10.39%1.52B | -0.78%6.16B | 17.16%4.27B | 29.27%3.2B | 14.78%1.69B | 26.97%6.21B | 10.79%3.65B | 4.49%2.47B |
| Cash received relating to other operating activities | 49.11%103.8M | 35.75%70.44M | 87.38%40.74M | -17.23%133.4M | -32.88%69.61M | 55.90%51.89M | 69.39%21.74M | -26.70%161.16M | 84.10%103.71M | -38.36%33.29M |
| Cash inflows from operating activities | -39.87%2.61B | -34.68%2.12B | -9.15%1.56B | -1.20%6.3B | 15.78%4.34B | 29.62%3.25B | 15.25%1.71B | 24.66%6.37B | 12.03%3.75B | 3.53%2.51B |
| Goods services cash paid | -22.99%1.36B | -14.11%1.09B | 16.65%707.69M | 27.41%2.46B | 39.47%1.77B | 46.70%1.27B | 35.81%606.71M | 8.19%1.93B | 4.16%1.27B | 3.62%867.07M |
| Staff behalf paid | 7.81%500.06M | 9.65%354.91M | 2.90%170.04M | 8.14%611.93M | 8.38%463.86M | 8.61%323.68M | 2.97%165.25M | 7.39%565.86M | 8.44%427.98M | 10.54%298.02M |
| All taxes paid | -22.16%422.33M | -27.98%299.95M | -22.80%176.11M | 24.77%723.41M | 58.34%542.54M | 73.75%416.51M | 71.81%228.12M | 2.56%579.81M | -11.94%342.64M | -17.51%239.72M |
| Cash paid relating to other operating activities | -38.50%724.23M | -39.94%517.55M | -35.71%298.42M | 21.97%1.62B | 26.77%1.18B | 41.29%861.68M | 46.89%464.17M | -3.53%1.33B | -2.33%928.99M | 6.17%609.87M |
| Cash outflows from operating activities | -23.88%3.01B | -21.19%2.26B | -7.65%1.35B | 22.94%5.41B | 33.19%3.95B | 42.65%2.87B | 38.66%1.46B | 3.55%4.4B | 0.52%2.97B | 2.19%2.01B |
| Net cash flows from operating activities | -203.01%-399.17M | -137.83%-142.16M | -17.97%204.29M | -54.96%889.69M | -50.39%387.52M | -23.68%375.78M | -42.17%249.03M | 128.30%1.98B | 98.30%781.19M | 9.39%492.36M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 103.59%3.4B | 56.46%2.3B | 300.00%1B | 4.53%2.27B | -0.10%1.67B | -12.07%1.47B | -28.57%250M | 81.97%2.17B | 209.57%1.67B | 234.34%1.67B |
| Cash received from returns on investments | 17.20%31.16M | 8.14%26.88M | 1,072.85%20.82M | 53.19%33.61M | 31.69%26.59M | 23.15%24.86M | -67.36%1.77M | 11.02%21.94M | 100.14%20.19M | 117.91%20.19M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -7.66%1.11M | -97.54%27.46K | ---- | 1.90%4.05M | -33.40%1.2M | -32.61%1.12M | 687.13%795K | 477.97%3.98M | 177.97%1.81M | 212.41%1.65M |
| Cash inflows from investing activities | 102.16%3.43B | 55.54%2.33B | 304.17%1.02B | 5.01%2.31B | 0.24%1.7B | -11.67%1.5B | -28.96%252.57M | 81.04%2.2B | 207.53%1.69B | 232.20%1.69B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -28.81%77.47M | -37.82%50.83M | -61.53%13.99M | -2.44%149.16M | -5.89%108.82M | -5.61%81.76M | -44.09%36.35M | 29.23%152.9M | 23.19%115.62M | 85.32%86.62M |
| Cash paid to acquire investments | 91.32%3.1B | 47.54%1.8B | ---- | -21.07%2.12B | -25.31%1.62B | -37.40%1.22B | -92.45%20M | 35.53%2.69B | 73.77%2.17B | 119.98%1.95B |
| Cash outflows from investing activities | 83.76%3.18B | 42.18%1.85B | -75.18%13.99M | -20.07%2.27B | -24.32%1.73B | -36.05%1.3B | -82.92%56.35M | 35.10%2.84B | 70.23%2.28B | 118.24%2.04B |
| Net cash flows from investing activities | 911.83%254.8M | 145.13%476.08M | 413.11%1.01B | 105.62%36.2M | 94.69%-31.39M | 156.78%194.22M | 668.66%196.22M | 27.57%-644.43M | 25.30%-591.23M | 19.12%-342.07M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -21.00%22.13M | -41.68%16.33M | ---- |
| Cash from borrowing | ---- | ---- | ---- | -97.62%10M | -97.58%10M | -96.55%10M | --10M | 37.00%420M | 34.99%413.86M | 13.03%290M |
| Cash received relating to other financing activities | ---- | ---- | ---- | --4.43M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | ---- | ---- | ---- | -96.74%14.43M | -97.68%10M | -96.55%10M | --10M | 32.14%442.13M | 28.58%430.2M | 5.50%290M |
| Borrowing repayment | -97.62%10M | -97.44%10M | ---- | 79.82%420M | 75.61%420M | 77.85%390M | ---- | -39.09%233.57M | -7.50%239.17M | -10.66%219.29M |
| Dividend interest payment | 48.99%925.33M | 46.11%902.27M | -97.29%92.26K | 39.11%626.79M | 41.95%621.08M | 42.66%617.51M | 816.56%3.4M | 86.29%450.57M | 89.61%437.55M | 1,391.69%432.85M |
| -Including:Cash payments for dividends or profit to minority shareholders | 29.91%40.63M | -17.57%25.78M | ---- | 13.03%38.28M | -8.06%31.28M | -8.06%31.28M | ---- | 14.10%33.87M | 13.27%34.02M | 171.10%34.02M |
| Cash payments relating to other financing activities | --7.47M | --3.41M | --923.53K | 42.05%6.47M | ---- | ---- | ---- | -75.45%4.56M | ---- | ---- |
| Cash outflows from financing activities | -9.44%942.8M | -9.11%915.67M | -70.13%1.02M | 52.94%1.05B | 53.84%1.04B | 54.49%1.01B | -81.12%3.4M | 6.95%688.69M | 38.29%676.71M | 119.96%652.14M |
| Net cash flows from financing activities | 8.56%-942.8M | 8.20%-915.67M | -115.39%-1.02M | -321.32%-1.04B | -318.26%-1.03B | -175.45%-997.51M | 136.63%6.6M | 20.29%-246.57M | -59.31%-246.52M | -1,575.87%-362.14M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -687.80%-536.07K | -140.95%-103.4K | -2,623.75%-134.38K | 1,466.35%231.54K | --91.2K | --252.54K | ---4.93K | ---16.95K | ---- | ---- |
| Net increase in cash and cash equivalents | -61.18%-1.09B | -36.18%-581.86M | 167.79%1.21B | -110.39%-112.71M | -1,093.30%-674.86M | -101.68%-427.26M | 3.13%451.84M | 424.83%1.08B | 89.76%-56.55M | -3,930.09%-211.85M |
| Add:Begin period cash and cash equivalents | -4.70%2.29B | -4.70%2.29B | -4.70%2.29B | 82.52%2.4B | 82.52%2.4B | 82.52%2.4B | 81.68%2.4B | -20.26%1.31B | -20.26%1.31B | -20.26%1.31B |
| End period cash equivalent | -30.49%1.2B | -13.56%1.7B | 22.64%3.5B | -4.70%2.29B | 37.06%1.72B | 78.83%1.97B | 62.11%2.85B | 82.52%2.4B | 14.78%1.26B | -33.34%1.1B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
